Lipoprotein Biomarkers and Heart Disease - DrJockers.com

Lipoprotein Biomarkers and Heart Disease

LiprotenCover

Lipoprotein a Lp (a) and Heart Disease:

The twenty-first century has seen a significant rise in research looking deeper into cholesterol subparticles.  Lipoprotein (a) or Lp(a) is a small LDL-like particle that has emerged as a major risk factor in heart disease, stroke and other cardiovascular problems (1, 2, 3).

Studies have shown that the higher Lp(a) levels in the blood are directly correlated with more plaque in the arteries and greater risk of cardiovascular disease.  There are natural strategies to utilize to lower Lp(a) levels.

cardiopowertests1

What is Lp (a):

Lipoproteins are molecules of fat (lipo) and protein that carry cholesterol molecules and fat soluble vitamins through the blood.  Lp(a) is a particular subtype of LDL cholesterol that is bound to a protein called apolipoprotein (a) (4).

Lp(a) is known to accumulate in plaques and promote atherosclerosis in the walls of the arteries.  It is also involved with blood coagulation and increased risk of blood clots within blood vessels (5, 6).

Lp(a)-pro-atherogenesis

Factors Involved With Elevated Lp(a)

Elevated Lp(a) is thought to be a genetic factor and levels are not influenced by diet, exercise, weight loss, stress or other environmental factors.   Lp(a) is one of the major issues involved in cardiovascular disease.  In fact, many leading experts believe that Lp(a) abnormalities are the key factor in younger individuals (30’s-50’s) having heart attacks (7, 8).

Most conventional lipid panels never measure Lp(a) levels but more sophisticated tests such as the Vertical AutoProfile (VAP) and the Lipoprotein Particle Profile include Lp(a).  A normal Lp(a) is less than 30 mg/dL.  Anyone with a level of Lp(a) greater than 30 mg/DL has a significantly increased risk of heart disease.

Individuals with low thyroid function often have higher Lp(a) levels (9, 10).   Individuals who have genetically elevated Lp(a) should be proactive about taking care of their thyroid.  Elevated Lp(a) levels can also cause high blood pressure, especially in women over 55 years old.  There is often a triad effect of low thyroid, high blood pressure and elevated Lp(a) levels.

Lifestyle Tips to Stabilize Lp(a):

Individuals with elevated Lp(a) must take good measure to reduce inflammation.  Elevated Lp(a) is like a gas leak in the house and inflammation is the spark that sets off the fire.  To keep inflammation down, one should be on a ketogenic diet keeping carbohydrates to a minimum.

The goal should be 60-80% of calories coming from good fat sources such as coconut products, avocado, olive oil, pasture-raised butter, pastured egg yolk and low carbohydrate nuts and seeds.  The good fats, and in particular healthy saturated fats, help to reduce Lp(a) levels.  Clean protein from grass-fed beef and pasture raised poultry should make up 10-25% of calories.  Be careful not to overcook meat and oils as this elevates the production of inflammatory free radicals.

Carbohydrates have been shown to elevate Lp(a) levels so these individuals should keep carbohydrates in the 10-15% of calorie load range.  It is best to stick with non-starchy vegetables, low-glycemic fruit such as berries, lemons and limes as carbohydrate sources.  They should only use stevia as a sweetener as the fructose content of other natural sweeteners such as honey, coconut nectar and maple syrup will drive up their inflammation and Lp(a) levels.

QD3352_Inflammation_video_title_page

Hormones and Lp(a) Levels:

Hormones levels have a very important influence over Lp(a) levels.  Improving DHEA and testosterone levels will lower Lp(a) levels in men and improving DHEA and estrogen/progesterone balance in women will help to lower Lp(a) levels (11, 12, 13).

The proper lifestyle activities including good sleep cycles (going to bed early and waking up early) and high intensity exercise are key for healthy hormones.  They must use good stress reduction techniques to minimize heavy periods of mental and emotional stress.

It is also adviseable to supplement with omega-3 fatty acids EPA and DHA as well as vitamin D.  The individual at risk should take great care of their gut and adrenals by using probiotics, and adrenal adaptogens and consuming a diet rich in anti-oxidants and naturally fermented foods.  Good fats as explained above are the building blocks for healthy hormones and should be the foundation for this nutrition plan.

FATBURNINGFOODSOPTIN BANNER

Supplementation to Lower Lp(a):

High doses of vitamin B3 or Niacin is the most effective way to bring down Lp(a) levels (14, 15).  The challenge with high doses of niacin is that it causes annoying hot flushes where the face and neck get red and the individual feels very warm.  This is quite scary for the individual if they are not educated on the flush beforehand and most doctors do not understand that this is a normal phenomenon.

Famed cardiologist and author of the NY Times best selling book “Wheat Belly,” Dr William Davis offers this advice.  In order to tolerate niacin, one must take it with a large meal such as dinner and hydrate vigorously.  Dr Davis advises patients to drink 2 (8-12 oz) glasses of water to put out the flush.  He believes this will work for 90%.  He advises to never take the niacin more than once per day for any long-acting preparation and twice daily for immediate release (16).

Other key supplements include CoQ10, N Acetyl Cysteine, Acetyl-L-carnitine and alpha lipoic acid to boost mitochondrial health (17, 18, 19, 20).  I put my clients with elevated Lp (a) on Brain SuperCharge which contains clinical verified dosages of these mitochondrial enhancing nutrients.

BrainSuperChargeCapsulesHeader_grande

Sources For This Article Include:

  1. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis. 1988 Jul-Aug;8(4):398-401. PMID: 2969235
  2. Davidoff P. [LP (a) lipoprotein: a new independent risk factor for atherogenesis]. Rev Med Chil. 1991 Jan;119(1):64-8. PMID: 1840458
  3. Marcovina SM, Hegele RA, Koschinsky ML. Lipoprotein(a) and coronary heart disease risk. Curr Cardiol Rep. 1999 Jul;1(2):105-11. PMID: 10980828
  4. MedlinePlus – Lipoprotein-a
  5. Beisiegel U, Niendorf A, Wolf K, Reblin T, Rath M. Lipoprotein(a) in the arterial wall. Eur Heart J. 1990 Aug;11 Suppl E:174-83. PMID: 2146123
  6. Smith EB, Cochran S. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)). Atherosclerosis. 1990 Oct;84(2-3):173-81. PMID: 2149268
  7. Enas EA. Lipoprotein(a) as a determinant of coronary heart disease in young women: a stronger risk factor than diabetes? Circulation. 1998 Jan 27;97(3):293-5. PMID: 9462536
  8. Tsimikas S, Hall JL. Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. J Am Coll Cardiol. 2012 Aug 21;60(8):716-21. PMID: 22898069
  9. Martínez-Triguero ML, Hernández-Mijares A, Nguyen TT, Muñoz ML, Peña H, Morillas C, Lorente D, Lluch I, Molina E. Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism. Mayo Clin Proc. 1998 Sep;73(9):837-41. PMID: 9737219
  10. Duntas LH. Thyroid disease and lipids. Thyroid. 2002 Apr;12(4):287-93. PMID: 12034052
  11. Zmunda JM, Thompson PD, Dickenson R, Bausserman LL. Testosterone decreases lipoprotein(a) in men. Am J Cardiol. 1996 Jun 1;77(14):1244-7. PMID: 8651107
  12. Marcovina SM, Lippi G, Bagatell CJ, Bremner WJ. Testosterone-induced suppression of lipoprotein(a) in normal men; relation to basal lipoprotein(a) level. Atherosclerosis. 1996 Apr 26;122(1):89-95. PMID: 8724115
  13. Ricci G, Tamaro G, Simeone R, Giolo E, Nucera G, De Seta F, Guaschino S. Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH. Hum Reprod. 2001 Mar;16(3):449-56. PMID: 11228210
  14. Pan J, Van JT, Chan E, Kesala RL, Lin M, Charles MA. Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes. Metabolism. 2002 Sep;51(9):1120-7. PMID: 12200755
  15. Pan J, Lin M, Kesala RL, Van J, Charles MA. Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes. Diabetes Obes Metab. 2002 Jul;4(4):255-61. PMID: 12099974
  16. Life Extension Magazine – Using Niacin to Improve Cardiovascular Health Link Here
  17. Serum concentration of lipoprotein(a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role. Int J Cardiol. 1999 Jan;68(1):23-9. PMID: 10077397
  18. Shojaei M, Djalali M, Khatami M, Siassi F, Eshraghian M. Effects of carnitine and coenzyme Q10 on lipid profile and serum levels of lipoprotein(a) in maintenance hemodialysis patients on statin therapy. Iran J Kidney Dis. 2011 Mar;5(2):114-8. PMID: 21368390
  19. Harding SV, Rideout TC, Jones PJ. Evidence for using alpha-lipoic acid in reducing lipoprotein and inflammatory related atherosclerotic risk. J Diet Suppl. 2012 Jun;9(2):116-27. PMID: 22607646
  20. Gavish D, Breslow JL. Lipoprotein(a) reduction by N-acetylcysteine. Lancet. 1991 Jan 26;337(8735):203-4. PMID: 1670844

Print Friendly

Comments

comments

,

Get Your FREE Guide to the SuperCharged Recipe Plan - Click to Learn More
No comments yet.

Leave a Reply